Please assess the completion status of the following clinical trial:

Trial Title: A Clinical Study to Evaluate the Clinical Performance and Safety of LiquiBand FIX8® Versus AbsorbaTack™ for Hernia Mesh Fixation and Peritoneal Closure in Groin Hernia Repair

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Is male or female, ≥22 years of age~Is willing and able to give written informed consent~Has a primary or recurrent groin hernia (unilateral or bilateral, inguinal or femoral)~Is currently scheduled and eligible for TAPP or TEP laparoscopic groin hernia repair (inguinal or femoral)~Hernia mesh to be used at the time of surgery is at least 4 x 6 in size and is one of the following;~* 3D Max™ Mesh (Bard Inc.)~* 3D Max™ Light (Bard Inc.)~* Parietex™ 2D (order code starting with TEC) Flat Sheet Mesh (Medtronic)~* Parietex™ 3D (order code starting with TET) Flat Sheet Mesh (Medtronic)~Is willing and able to comply with the protocol assessments at time of surgery and during the post surgical follow up period~Exclusion Criteria:~Has a hernia type not suitable for laparoscopic hernia repair as determined by the Investigator (i.e. strangulated)~Subject has a recurrent groin hernia previously repaired laparoscopically, has an anatomical defect or had prior surgical procedures that in the opinion of the Investigator prevents access to the pre-peritoneal space for TAPP or TEP laparoscopic hernia repair~Is pregnant or actively breastfeeding~Has a known sensitivity to cyanoacrylate or formaldehyde,D\&C Violet No.2 dye or any component of LiquiBand FIX8® or control device~Has an active or potential infection at the surgical site or systemic sepsis~Hernia mesh to be used at surgery is less than 4x6 in size, or not one of the types of mesh listed in Inclusion Criteria above~Cannot tolerate general anaesthesia~Has any significant or unstable medical or psychiatric condition that, in the opinion of the Investigator, would interfere with his/her ability to participate in the study

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- LiquiBand FIX8® (Type: EXPERIMENTAL): LiquiBand FIX8® is an n-butyl-2-cyanoacrylate adhesive monomer and D\&C Violet #2 dye
- AbsorbaTack™ (Type: ACTIVE_COMPARATOR): AbsorbaTack™ is an absorbable synthetic polyester copolymer derived from lactic and glycolic acid and is dyed with D\&C Violet No. 2

Based on this trial design, predict the completion outcome and termination type (if applicable).